These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12062429)

  • 1. The dystrophin gene is alternatively spliced throughout its coding sequence.
    Sironi M; Cagliani R; Pozzoli U; Bardoni A; Comi GP; Giorda R; Bresolin N
    FEBS Lett; 2002 Apr; 517(1-3):163-6. PubMed ID: 12062429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles.
    Sironi M; Cagliani R; Comi GP; Pozzoli U; Bardoni A; Giorda R; Bresolin N
    FEBS Lett; 2003 Feb; 537(1-3):30-4. PubMed ID: 12606026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain.
    Austin RC; Morris GE; Howard PL; Klamut HJ; Ray PN
    Neuromuscul Disord; 2000 Mar; 10(3):187-93. PubMed ID: 10734266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.
    Rafael JA; Sunada Y; Cole NM; Campbell KP; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1994 Oct; 3(10):1725-33. PubMed ID: 7849695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.
    Arechavala-Gomeza V; Graham IR; Popplewell LJ; Adams AM; Aartsma-Rus A; Kinali M; Morgan JE; van Deutekom JC; Wilton SD; Dickson G; Muntoni F
    Hum Gene Ther; 2007 Sep; 18(9):798-810. PubMed ID: 17767400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
    Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
    J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
    Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
    Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion.
    Gualandi F; Trabanelli C; Rimessi P; Calzolari E; Toffolatti L; Patarnello T; Kunz G; Muntoni F; Ferlini A
    J Med Genet; 2003 Aug; 40(8):e100. PubMed ID: 12920092
    [No Abstract]   [Full Text] [Related]  

  • 9. Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing.
    Surono A; Takeshima Y; Wibawa T; Ikezawa M; Nonaka I; Matsuo M
    Hum Mol Genet; 1999 Mar; 8(3):493-500. PubMed ID: 9949208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.
    Bies RD; Phelps SF; Cortez MD; Roberts R; Caskey CT; Chamberlain JS
    Nucleic Acids Res; 1992 Apr; 20(7):1725-31. PubMed ID: 1579466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.
    Tandon A; Jefferies JL; Villa CR; Hor KN; Wong BL; Ware SM; Gao Z; Towbin JA; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
    Am J Cardiol; 2015 Apr; 115(7):967-71. PubMed ID: 25702278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
    Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
    Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5' region of the dystrophin gene in human skeletal muscle.
    Surono A; Takeshima Y; Wibawa T; Pramono ZA; Matsuo M
    Biochem Biophys Res Commun; 1997 Oct; 239(3):895-9. PubMed ID: 9367866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
    Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
    Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
    Lu QL; Mann CJ; Lou F; Bou-Gharios G; Morris GE; Xue SA; Fletcher S; Partridge TA; Wilton SD
    Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot.
    Suzuki H; Aoki Y; Kameyama T; Saito T; Masuda S; Tanihata J; Nagata T; Mayeda A; Takeda S; Tsukahara T
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.